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Introduction: Most studies have analyzed pre-arrest and resuscitation factors associated with mortality after cardiac arrest
(CA) in children, but many patients that reach return of spontaneous circulation die within the next days or weeks. The
objective of our study was to analyze post-return of spontaneous circulation factors associated with in-hospital mortality
after cardiac arrest in children.
Methods: A prospective multicenter, multinational, observational study in 48 hospitals from 12 countries was performed.
A total of 502 children aged between 1 month and 18 years with in-hospital cardiac arrest were analyzed. The primary
endpoint was survival to hospital discharge. Univariate and multivariate logistic regression analyses were performed to
assess the influence of each post-return of spontaneous circulation factor on mortality.
Results: Return of spontaneous circulation was achieved in 69.5% of patients; 39.2% survived to hospital discharge and
88.9% of survivors had good neurological outcome. In the univariate analysis, post- return of spontaneous circulation fac-
tors related with mortality were pH, base deficit, lactic acid, bicarbonate, FiO2, need for inotropic support, inotropic index,
dose of dopamine and dobutamine at 1 hour and at 24 hours after return of spontaneous circulation as well as Pediatric
Intensive Care Unit and total hospital length of stay. In the multivariate analysis factors associated with mortality at 1 hour
after return of spontaneous circulation were PaCO2 < 30 mmHg and >50 mmHg, inotropic index >14 and lactic acid
>5 mmol/L. Factors associated with mortality at 24 hours after return of spontaneous circulation were PaCO2 > 50 mmHg,
inotropic index >14 and FiO2≥ 0.80.
Conclusions: Secondary in-hospital mortality among the initial survivors of CA is high. Hypoventilation,
hyperventilation, FiO2 ≥ 0.80, the need for high doses of inotropic support, and high levels of lactic acid were
the most important post-return of spontaneous circulation factors associated with in-hospital mortality in
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Most studies have analyzed pre-arrest and resuscitation fac-
tors associated with mortality after cardiac arrest (CA) in
children [1-13]. Previous studies have shown that lower hu-
man development index of countries, characteristics of the
hospital, CA that occurred out of hospital and out of the
Pediatric Intensive Care Unit (PICU), oncohematologic dis-
ease, treatment with inotropic drugs at the time of the CA,
CA due to neurological disease or sepsis, time to the initi-
ation of resuscitation, asystole as the initial electrocardio-
graphic (ECG) rhythm, need for adrenaline, bicarbonate or
fluid expansion and the duration of cardiopulmonary resus-
citation (CPR) are associated with higher mortality [1-13].
An important percentage of patients that reach return
of spontaneous circulation (ROSC) die within the next
days or weeks. However, there are no multicenter, multi-
national prospective studies on CA in children to have
analyzed post-ROSC prognostic factors. In previous
studies performed on the same prospective register we
have analyzed the pre-arrest and resuscitation factors
[11] and the ventilation and oxygenation factors associ-
ated with mortality [14]. The objective of the present
study was to analyze the factors affecting mortality and
neurological outcome of in-hospital CA in children. The
hypothesis was that respiratory status and hemodynamic
status are the most important prognosis factors after
ROSC in children.
Methods
An open multicenter prospective study was designed
and information and an invitation to participate were
sent to the pediatric departments and PICUs of hospitals
in Latin-American countries, Spain, Portugal, and Italy.
The study was approved by local Institutional Review
Boards (Additional file 1). Registration on the website
[15] was necessary to participate in the study. Consent
of parents of patients was not considered necessary be-
cause it was an observational study during and after CA
and it is necessary to obtain data immediately.
A protocol was drawn up in accordance with the
Utstein style [16,17]. Children aged from 1 month
to 18 years who suffered in-hospital CA between
December 2007 and December 2009 were included. CA
was defined by the presence of all the following signs:
unresponsiveness, apnea, absence of signs of life and ab-
sence of a palpable central pulse or bradycardia with
less than 60 beats per minute (bpm) with poor perfusion
in infants requiring external cardiac compressions and
assisted ventilation.
All data were entered via a secure, encrypted website
and were electronically submitted to the coordinating
center. That center performed a review of all records to
ensure data quality, and site investigators were queried
to complete missing data and resolve discrepancies.Patient-related variables and arrest and life support-
related parameters have been previously published [11] and
also the relationship between ventilation and oxygenation
with mortality [14]. In the present study we analyzed the in-
fluence on survival of several post-ROSC parameters, such
as arterial gasometry and lactic acid at the first hour and
24 hours after ROSC, the need for mechanical ventilation,
recovery of spontaneous breathing (although mechanical
ventilation could be needed), the need for vasoactive drugs
and doses of vasoactive drugs, vasoactive-inotropic index
(VIS) [18], and ECG rhythm after ROSC. Hospital course
and clinical and neurological status at hospital discharge
according to the pediatric cerebral performance category
[PCPC] were registered [19]. Variable definitions were
based on Utstein-style guidelines [16,17]. The primary end-
point was survival to hospital discharge. The secondary out-
come measure was neurological status at hospital
discharge; a good neurological status was defined as a
PCPC score of 1 or 2 [19].
Statistical analyses were conducted using SPSS software
version 18.1 (SPSS Inc, Chicago, IL, USA). Outcomes were
compared between groups using the chi-square (χ2) test or
Fisher’s exact test for categorical variables. Univariate and
multivariate logistic regression analysis was performed to
assess the influence of each one of the factors on mortality.
A logistic regression model was constructed for variables at
1 hour and at 24 hours after ROSC. All individual factors
with statistical significance in the univariate analysis and
P <0.1 were eligible for inclusion in the logistic regression
model. Receiver operator characteristic (ROC) curves were
used to decided cutoffs values for VIS and lactic acid. Ven-
tilation and oxygenation cutoff values were chosen accord-
ing to previous studies [20,21] and normal limits of pH,
ventilation and oxygenation. Finally a logistic regression
model was constructed including patient-related variables,
arrest- and life support-related parameters, and post-ROSC
parameters. Adjusted odds ratios (OR) and 95% confidence
intervals (CI) were calculated for each model. ROC curves
were used to assess the predictive capacity of each model.
Results
Forty-eight hospitals from twelve countries participated
in the study. The analysis included 563 episodes of in-
hospital CA in 502 patients. CA occurred in the PICU
in 50% of cases, in the emergency department in 26.8%,
and in other hospital areas in 23.2%.
Return of spontaneous circulation (ROSC) for more
than 20 minutes was achieved in 349 patients (69.5%),
but 152 (30.3%) patients died later in hospital due to
new CA (32.9%), multiple organ dysfunction (27%),
limitation of medical therapy (25%) or brain death
(15.1%): 197 patients (39.2%) survived to hospital dis-
charge. Five patients were rescued with extracorporeal
membrane oxygenation (ECMO) during CPR and four
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tics of the 502 patients, pre-arrest factors, and cardiac
arrest and resuscitation factors associated with mortality
have been previously published [11].
Post-ROSC factors associated with mortality
Table 1 shows the comparison between survivors and
non-survivors in post-ROSC factors. Non-survivors had
lower pH, higher base excess, higher lactic acid levels and
higher inspired oxygen fraction (FiO2) at 1 and 24 hours
after ROSC than survivors. A greater percentage of non-
survivors needed inotropic support, and they required
higher doses of dopamine and dobutamine, and had a
higher inotropic score than survivors did. Nevertheless,
the percentage of patients receiving milrinone was lower
in non-survivors than in survivors. When patients without
inotropic support before CA were analyzed separately,
children who required inotropic support after ROSC hadTable 1 Comparison between survivors and non-survivors
Number of
patients
N
M
Gasometry at 1 h
pH 259
PaO2, mmHg 253
PaO2/FiO2 231 8
PaCO2, mmHg 255
HCO3 mEq/L 241
BE 233
Lactic acid, mmol/L 136
FiO2 249
Gasometry at 24 h
pH 209
PaO2, mmHg 205
PaO2/FiO2 178 1
PaCO2, mmHg 208
HCO3, mEq/L 205
BE 186
Lactic acid, mmol/L 123
FiO2 191
Lactic acid clearance, % 99
Mechanical ventilation after ROSC, % 215
Vasoactive treatment
Patients with vasopressors after ROSC, % 173
Inotropic score after ROSC 154
Length of stay
Days in the PICU 224
Days in hospital ward 118
Significant values marked in bold. BE, base excess; PICU, Pediatric ICU; ROSC, return
pressure of oxygen.42.1% higher mortality than those who did not need it
26.9% (P =0.036). Finally, the length of PICU stay and total
hospital stay was shorter in non-survivors.
Table 2 summarizes post-ROSC factors and their rela-
tionship with survival to hospital discharge in the univari-
ate regression analysis. The need for inotropic support, an
inotropic index greater than 14, the absence of spontan-
eous breathing, PaCO2 < 30 mmHg or >50 mmHg, FiO2 ≥
0.80 and lactic acid levels >5 mmol/L at 1 hour after
ROSC, as well as pH <7.30, PaCO2 > 50 mmHg and
FiO2 > 50% at 24 hours after ROSC were significantly
associated with higher mortality rates. There were no
significant differences in post-ROSC PaO2 between sur-
vivors and non-survivors patients, even when the 24
patients with cyanotic heart disease and 6 patients on
ECMO were excluded of analysis.
In the multivariate analysis, factors associated with
mortality at 1 hour after ROSC were PaCO2 < 30 mmHgon-survivors Survivors P-value
edian (IQR) Median (IQR)
7.23 (7.03 to 7.35) 7.29 (7.17 to 7.38) 0.004
78.5 (45.0 to 125.0) 81.0 (47.0 to 136.0) 0.476
5.5 (50.75 to 189.5) 111 (63 to 242) 0.101
46 (32 to 63) 42 (34 to 52) 0.314
18 (12.0 to 24.5) 21 (15 to 25) 0.064
-8 (-2 to -15) -6 (-0.75 to -12) 0.049
7.2 (7 to 13) 4.1 (1.89 to 8) 0.002
100 (72.5 to 100) 100 (50 to 100) 0.034
7.35 (7.26 to 7.42) 7.40 (7.34 to 7.45) 0.001
77 (50 to 124) 82 (49.75 to 119.25) 0.924
25 (70.25 to 242.08) 111 (63 to 242) 0.031
42.5 (34.25 to 53.5) 41 (35 to 46) 0.175
22 (19 to 27) 25 (21 to 29) 0.009
-2 (-5 to 3.1) 1 (-3 to 5) 0.031
2 (1.2 to 6.47) 1.4 (0.9 to 2.25) 0.007
80(50 to 100) 45 (30 to 65) 0.001
60 (25 to 75) 68.63 (27.81 to 84.70) 0.385
94.4 93.5 0.756
76.3 63.9 0.039
80.7 (121.6) 38.3 (78.7) 0.001
7.9 (14.7) 17.4 (19.4) 0.001
4.5 (6.9) 17.3 (19.4) 0.001
of spontaneous circulation; FiO2, inspired oxygen fraction; PaO2, arterial partial
Table 2 Univariate analysis of mortality according to post-return of spontaneous circulation factors
Patients, number Patients, % Mortality, % Odds ratio 95% CI P-value
Mechanical ventilation
No 42 6.1 41.2 1
Yes 173 93.9 45 3.273 0.713 to 15.027 0.127
Vasoactive drugs
No 79 31.3 29.1 1
Yes 173 68.7 42.8 1.820 1.028 to 3.222 0.040
Vasoactive-inotropic score
<14 62 40.3 29 0.390
>14 92 59.7 51 2.564 1.288 to 5.050 0.007
Electrocardiographic rhythm after ROSC
Sinus rhythm 230 72.8 43.5 1
Other rhythms 86 27.2 53.5 1.495 0.909 to 2.459 0.113
Recovery of spontaneous breathing
Yes 86 26 22.1 1
No 245 74 57.1 4.694 2.659 to 8.333 0.001
pH 1 h
7.30 to 7.50 96 37.1 37.5 1
<7.30 154 59.5 48.7 1.582 0.941 to 2.662 0.084
>7.50 9 3.5 22.2 0.476 0.094 to 2.418 0.371
PaO2 1 h
60 to 200 mmHg 123 48.6 44.7 1
<60 mmHg 96 37.9 43.8 0.962 0.562 to 1.646 0.887
>200 mmHg 34 13.4 32.4 0.591 0.265 to 1.318 0.199
PaCO2 1 h
30 to 50 mmHg 133 52.2 33.1 1
<30 mmHg 37 14.5 62.2 3.323 1.560 to 7.079 0.002
>50 mmHg 85 33.3 52.9 2.276 1.302 to 3.978 0.004
CO3H 1 h
20 to 26 mEq/L 75 31.1 36 1
<20 mEq/L 118 49 46.6 1.552 0.857 to 2.812 0.147
>26 mEq/L 48 19.9 41.7 1.27 0.604 to 2.669 0.528
Base excess 1 h
+4 to -4 48 20.6 37.5 1
<-4 154 66.1 46.8 1.463 0.753 to 2.844 0.261
> + 4 31 13.3 41.9 1.204 0.479 to 3.027 0.694
FiO2 1 h
<0.50 42 16.7 12.1 1
0.50 to 0.79 41 16.3 12.9 1.150 0.468 to 2.847 0.756
≥0.80 169 67.1 75 2.120 1.044 to 4.311 0.038
PaO2/FiO2 1 h
>300 166 16.7 45.5 1
200 to 300 37 11.7 25.8 0.417 0.154 to 1.134 0.087
<200 28 71.6 46 1.024 0.530 to 1.978 0.945
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Table 2 Univariate analysis of mortality according to post-return of spontaneous circulation factors (Continued)
Lactic acid 1 h
<2 mmol/L 27 19.9 22.2 1
2 to 5 mmol/L 39 28.7 28.2 1.375 0.438 to 4.318 0.585
>5 mmol/L 70 51.5 51.4 3.706 1.335 to 10.29 0.012
pH 24 h
7.30 to 7.50 158 75.6 27.8 1
<7.30 39 18.7 53.8 3.023 1.472 to 6.205 0.003
>7.50 70 5.7 33.3 1.295 0.371 to 4.520 0.685
PaO2 24 h
60 to 200 mmHg 121 59 32.2 1
<60 mmHg 70 34.1 28.6 0.841 0.442 to 1.601 0.598
>200 mmHg 14 6.8 57.1 2.803 0.910 to 8.636 0.073
PaCO2 24 h
30 to 50 mmHg 123 68.3 25.2 1
<30 mmHg 14 7.8 35.7 1.649 0.513 to 5.294 0.401
>50 mmHg 43 23.9 51.2 3.109 1.508 to 6.409 0.002
CO3H 24 h
20 to 26 mEq/L 90 43.9 36.7 1
<20 mEq/L 41 20 43.9 1.352 0.638 to 2,865 0.432
>26 mEq/L 74 36.1 24.3 0.555 0.281 to 1,099 0.091
Base excess 24 h
+4 to -4 90 48.4 30 1
<-4 52 28 40.4 1.581 0.774 to 3.229 0.209
> + 4 44 23.7 22.7 0.686 0.297 to 1.585 0.378
FiO2 24 h
<0.50 80 41.9 22.1
0.50 to 0.79 48 25.1 25 2.376 1.051 to 5.371 0.038
≥0.80 63 33 52.9 5.778 2.726 to 12.245 0.001
PaO2/FiO2 24 h
>300 116 18.2 21.6 1
200 to 300 34 16.3 30.3 2.327 0.988 to 5.481 0.053
< 00 28 65.5 39.1 1.576 0.536 to 4.636 0.408
Lactic acid 24 h
<2 mmol/L 73 59.3 23.3 1
2 to 5 mmol/L 29 23.6 37.9 2.013 0.798 to 5.081 0.139
>5 mmol/L 21 17.1 47.6 2.995 1.086 to 8.254 0.034
Lactic acid clearance
>50% 56 55.9 28.8 1
≤50% 43 44.1 30.8 1.099 0.497 to 2.433 0.841
Significant values marked in bold. Lactid acid clearance: (lactate after ROSC minus lactate 24 hours after ROSC) × 100/lactate after ROSC. ROSC, return of
spontaneous of circulation; FiO2, inspired oxygen fraction; PaO2, arterial partial pressure of oxygen.
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>5 mmol/L (Table 3). Factors associated with mortality
at 24 hours after ROSC were PaCO2 > 50 mmHg, ino-
tropic index >14 and FiO2 ≥ 0.8 (Table 3).The logistic regression model at 1 hour after ROSC
had an AUC of 0.733 (CI 0.681 to 0.785; P =0.001). The
logistic regression model at 24 hours after ROSC had an
AUC of 0.769 (CI 0.720 to 0.819; P =0.001), (Figure 1).
Table 3 Multivariate logistic regression study including mortality risk factors at 1 hour and 24 hours after return of
spontaneous circulation
Odds ratio 95% CI P-value
1 hour after return of spontaneous circulation
PaCO2 < 30 mmHg 2.640 1.190 to 5.857 0.017
PaCO2 > 50 mmHg 1.950 1.063 to 3.576 0.031
Lactic acid >5 mmol/L 2.021 0.926 to 4.413 0.077
Vasoactive-inotropic score >14 2.454 1.252 to 4.810 0.009
24 hours after ROSC
PaCO2 > 50 mmHg 2.541 1.156 to 5.587 0.020
FiO2≥ 0.80 3.864 1.698 to 8.794 0.001
Vasoactive-inotropic score >14 2.070 1.008 to 4.249 0.047
López-Herce et al. Critical Care 2014, 18:607 Page 6 of 14
http://ccforum.com/content/18/6/607Post-ROSC factors associated with neurological outcome
Neurological status at hospital discharge was assessed in
120 patients (60.9%), and 107 of them (89%) had a nor-
mal neurological status or showed mild disability (PCPC
l or 2). PCPC before CA and at hospital discharge was
compared. Only 2.8% of patients with PCPC 1 or 2 be-
fore CA presented a PCPC >2 at hospital discharge.
When comparing patients with good and bad neuro-
logical outcome (PCPC >2), at 1 hour after ROSC those
with a bad outcome had significantly lower levels of bicar-
bonate (19.1 (7.4) mEq/L versus 21.8 (6.9) mEq/L;
P =0.025), higher lactic acid levels (8.1 (6.5) mmol/L versus
5.8 (11.3) mmol/L; P =0.003) and higher base excess (BE)
(-7.1 (9.4) mEq/L versus -3.4 (9.6) mEq/L; P =0.042)
(Table 4). A higher percentage of patients with bad neuro-
logical outcome received dobutamine (40.9%) than those
with good neurological outcome (19%) P =0.007 (Table 4).0.
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Figure 1 Receiver operator characteristic (ROC) curves of mortality-as
(ROSC) (area under the curve (AUC) 0.733, CI (0.681 to 0.785); P =0.00
P =0.001).The univariate analysis showed that dobutamine admin-
istration and lactic acid levels >5 mmol/L at 1 hour, and
pH >7.50, PaCO2 > 50 mmHg and BE >4 mEq/L at
24 hours after ROSC were associated with poor neuro-
logical evolution (Table 5).
In the multivariate analysis the only factor associated with
poor neurological outcome at 1 hour after ROSC was lactic
acid above 5 mmol/L (OR 9.902, CI (1.992 to 51.008);
P =0.006). None of the factors at 24 hours after ROSC
showed statistical significance in the multivariate analysis.
Pre-arrest, resuscitation and post-ROSC factors
The multivariate analysis including pre-arrest factors, re-
suscitation factors and post-ROSC factors is shown in
Table 6. Factors associated with in-hospital mortality
were hemato-oncologic illness, neurologic cause of ar-
rest, CA in the emergency department, treatment with1.00
Pr_1 ROC area: 0.7332
Pr_2 ROC area: 0.7692
Reference
sociated factors at 1 hour after return of spontaneous circulation
1) and at 24 hours after ROSC (AUC 0.769, CI (0.720 to 0.819);
Table 4 Comparison between patients with pediatric cerebral performance category (PCPC) 1 to 2 and those
with PCPC >2
PCPC 1 to 2 PCPC >2 P-value
Mean (SD) Mean (SD)
Gasometry 1 h
pH 7.29 (0.14) 7.24 (0.17) 0.120
PaO2, mmHg 118.0 (104.9) 88.3 (58.8) 0.330
PaO2/FiO2 175.1 (143.1) 121.2 (89.8) 0.111
PaCO2, mmHg 46.1 (14.5) 45.6 (19.4) 0.297
CO3H mEq/L 21.8 (6.9) 19.1 (7.4) 0.025
Base excess -3.4 (9.6) -7.1 (9.4) 0.042
Lactic acid, mmol/L 5.8 (11.3) 8.1 (6.5) 0.003
FiO2 77.9 (27.8) 76.8 (26.8) 0.867
Gasometry 24 h
pH 7.39 (0.08) 7.39 (0.12) 0.546
PaO2, mmHg 96.7 (66.0) 77.4 (40.3) 0.094
PaO2/FiO2 207.1 (132.7) 162.5 (119.8) 0.053
PaCO2, mmHg 42.7 (10.7) 43.8 (13.1) 0.681
CO3H, mEq/L 25.2 (5.0) 26.2 (6.7) 0.389
Base excess 0.6 (5.2) 1.5 (7.7) 0.710
Lactic acid, mmol/L 2.2 (2.9) 6.8 (20.7) 0.405
FiO2 53.3 (24.4) 57.9 (26.4) 0.425
Lactic acid clearance, % 37.1 (81.9) 72.6 (19.2) 0.009
Mechanical ventilation, % 94.4 97.4 0.667
Vasoactive treatment
Patients with pressors after ROSC, % 57.9 77.5 0.033
Inotropic score after ROSC 45.3 (78.4) 36.4 (52.6) 0.693
Patients with dopamine, % 34 43.2 0.349
Dopamine dose, mcg/kg/min 9.4 (4.9) 10.7 (5.9) 0.518
Patients with dobutamine, % 19 40.9 0.007
Dobutamine dose, mcg/kg/min 13.7 (8.1) 9.2 (4.9) 0.070
Patients with adrenaline, % 20 18.2 1.000
Adrenaline dose, mcg/kg/min 0.6 (0.6) 0.4 (0.1) 0.667
Patients with noradrenaline, % 12 13.6 0.789
Noradrenaline dose, mcg/kg/min 0.8 (0.7) 1.3 (0.9) 0.312
Patients with milrinone, % 20 11.4 0.241
Milrinone dose, mcg/kg/min 0.8 (0.2) 0.8 (0.3) 0.812
Length of stay
Days in the Pediatric ICU 17.3 (17.9) 22.3 (24.6) 0.610
Days in hospital ward 16.3 (18.1) 21.0 (26.0) 0.648
Significant values marked in bold. ROSC, return of spontaneous circulation.
López-Herce et al. Critical Care 2014, 18:607 Page 7 of 14
http://ccforum.com/content/18/6/607inotropic drugs before CA, administration of sodium bi-
carbonate, PaCO2 < 30 mmHg 1 hour after ROSC,
PaCO2 > 50 mmHg one hour after ROSC and FiO2 ≥
0.80 24 hours after ROSC.Discussion
To our knowledge, this is the first multicenter multi-
national study that analyzed the association of early
post-ROSC factors with outcome of in-hospital cardiac
Table 5 Univariate analysis of bad neurologic evolution (pediatric cerebral performance category (PCPC) >2) according
to post-return of spontaneous circulation (ROSC) factors
Patients, % PCPC >2, % Odds ratio 95% CI P-value
Patients
Mechanical ventilation
No 4.7 16.7 1.000
Yes 95.3 30.9 2.235 0.252 to 19.791 0.470
Vasoactive drugs
No 42.1 18.4 1.000
Yes 57.9 36 1.739 0.793 to 3.186 0.167
Adrenaline
No 80.6 31 1.000
Yes 19.4 28.6 0.889 0.358 to 2.207 0.800
Noradrenaline
No 87.5 30.2 1.000
Yes 12.5 33.3 1.158 0.405 to 3.313 0.785
Dopamine
No 63.2 27.5 1.000
Yes 36.8 35.8 1.475 0.714 to 3.049 0.294
Dobutamine
No 74.3 24.3 1.000
Yes 25.7 48.6 2.951 1.351 to 6.448 0.007
Milrinone
No 82.6 32.8 1.000
Yes 17.4 20 0.513 0.179 to 1.469 0.213
Vasoactive-inotropic score
<14 48.1 43.2 1.000
>14 51.9 35 0.707 0.282 to 1.772 0.459
Echocardiographic rhythm after ROSC
Sinus rhythm 74 27.8 1.000
Other rhythms 26 36.8 1.497 0.685 to 3.274 0.312
Recovery of spontaneous breathing
Yes 65.3 25.5 1.000
No 34.7 33.3 1.340 0.648 to 2.767 0.430
pH 1 h
7.30 to 7.50 40.8 21.6 1.000
<7.30 54.4 32.4 1.739 0.752 to 4.023 0.196
>7.50 4.8 33.3 1.818 0.293 to 11.265 0.521
PaO2 1 h
60 to 200 mmHg 45.2 33.3 1.000
<60 mmHg 40.5 29.4 0.833 0.368 to 1.885 0.661
>200 mmHg 14.3 16.7 0.400 0.103 to 1.553 0.186
PaCO2 1 h
30 to 50 mmHg 62.1 23.4 1.000
<30 mmHg 9.7 50 3.278 0.940 to 11.425 0.062
>50 mmHg 28.2 37.1 1.937 0.815 to 4.601 0.134
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Table 5 Univariate analysis of bad neurologic evolution (pediatric cerebral performance category (PCPC) >2) according
to post-return of spontaneous circulation (ROSC) factors (Continued)
CO3H 1 h
20 to 26 mEq/L 34.7 23.8 1.000
<20 mEq/L 44.6 38.9 2.036 0.831 to 4.991 0.120
>26 mEq/L 20.7 20 0.800 0.239 to 2.683 0.718
BE
+4 to -4 24.8 25 1.000
<-4 61.1 33.3 1.500 0.557 to 4.041 0.423
> + 4 14.2 18.8 0.692 0.152 to 3.163 0.635
FiO2 1 h
<0.50 50.9 25.5 1.000
0.50 to 0.79 25.9 32.1 1.125 0.324 to 3.909 0.853
≥0.80 23.1 44 1.125 0.409 to 3.097 0.820
PaO2/FiO2 1 h
>300 15.9 16.7 1.000
200 to 300 12.4 14.3 3.049 0.083 to 11.149 0.092
<200 71.7 34.6 1.286 0.224 to 7.370 0.778
Lactic acid 1 h
<2 mmol/L 21.3 6.2 1.000
2 to 5 mmol/L 37.3 25 3.520 0.675 to 18.366 0.135
>5 mmol/L 41.3 41.9 9.263 1.883 to 45.560 0.006
pH 24 h
7.30 to 7.50 80.6 26 1.000
<7.30 12.9 43.8 2.214 0.749 to 6.545 0.151
>7.50 6.5 62.5 4.744 1.059 to 21.248 0.042
PaO2 24 h
60 to 200 mmHg 58.5 29.2 1.000
< 60 mmHg 36.6 37.8 1.474 0.670 to 3.243 0.334
>200 mmHg 4.9 0 0
PaCO2 24 h
30 to 50 mmHg 76.9 24.1 1.000
<30 mmHg 5.6 50 3.150 0.589 to 16.859 0.180
>50 mmHg 17.6 52.6 3.500 1.248 to 9.819 0.017
CO3H 24 h
20 to 26 mEq/L 43 26.9 1.000
<20 mEq/L 15.7 26.3 0.969 0..295 to 3.189 0.959
>26 mEq/L 41.3 36 1.527 0.658 to 3.544 0.325
BE 24 h
+4 to -4 50 19.6 1.000
<-4 23.2 38.5 2.557 0.914 to 7.155 0.774
> + 4 26.8 46.7 3.580 1.351 to 9.482 0.010
FiO2 24 h
<0.50 21.4 28 1.000
0.50 to 0.79 19.7 30.4 1.387 0.511 to 3.765 0.521
≥0.80 59 30.4 2.301 0.850 to 6.229 0.100
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Table 5 Univariate analysis of bad neurologic evolution (pediatric cerebral performance category (PCPC) >2) according
to post-return of spontaneous circulation (ROSC) factors (Continued)
PaO2/FiO2 24 h
>300 21 13.6 1.000
200 to 300 17.1 22.2 3.128 0.974 to 10.049 0.056
<200 61.9 40 1.312 0.284 to 6.067 0.728
Lactic acid 24 h
<2 mmol/L 66.7 26.9 1.000
2 to 5 mmol/L 20.5 31.2 1.234 0.364 to 4.187 0.736
>5 mmol/L 12.8 40 1.810 0.444 to 7.380 0.408
Significant values marked in bold.
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lines. Sustained ROSC was achieved in 69.5% patients
but secondary in-hospital mortality among the initial
survivors of CA was 43.5% and survival to hospital dis-
charge was therefore 39.2%.
Oxygenation and ventilation parameters
Several studies, including our previous analysis, showed
that alterations in ventilation and oxygenation during the
first hours after ROSC are associated with prognosis
[14,20-24]. Our study shows that PaCO2 < 30 mmHg and
>50 mmHg at 1 hour and PaCO2 > 50 mmHg at 24 hours
after ROSC are mortality indicators [14]. Our results differ
from those reported in a retrospective study in 195 chil-
dren after CA, in which no relationship was found be-
tween ventilation and mortality [20]. Hyperventilation
may increase mortality and brain damage by reducing
cerebral blood flow and tissue perfusion resulting in ische-
mia [22]. On the other hand, hypoventilation may increase
the risk of cerebral edema and intracranial hypertension
due to cerebral vasodilation [23]. In addition, hypercapnia
can impair myocardial function and induce vasoconstric-
tion of the pulmonary vascular bed [23]. Our findings
highlight the importance of monitoring ventilation using
capnography and blood gas analysis in order to rapidly
achieve an appropriate ventilation status after ROSC,Table 6 Multivariate logistic regression study including pre-a
circulation (ROSC) mortality risk factors
Mortality risk factors O
Hemato-oncologic illness
Neurologic cause of cardiac arrest
Place of arrest (emergency department)
Inotropic drugs prior to cardiac arrest
Sodium bicarbonate administration during resuscitation
PaCO2 < 30 mmHg 1 h after ROSC
PaCO2 > 50 mmHg 1 h after ROSC
FiO2≥ 0.80 24 hours after ROSCalthough capnography values can be altered in patients
with abnormal PaO2/FiO2.
PaO2 was not associated with mortality in the univariate
or in the multivariate analysis at 1 hour and at 24 hours
after ROSC. Two recent retrospective studies in children
did not find this association between mortality and oxygen-
ation either [20,24]. Nevertheless, another retrospective
study that analyzed 1,875 pediatric patients found a correl-
ation between mortality in the PICU and hypoxia and, to a
lesser extent, with hyperoxia. This study did not analyze the
relationship between ventilation and mortality [21].
In our study, non-survivors had higher FiO2 than survi-
vors, and the univariate analysis showed that FiO2 ≥ 0.80
was associated with mortality. The multivariate logistic re-
gression study showed that high FiO2 could be considered
a risk factor only at 24 hours after ROSC. Elevated FiO2
may cause cellular toxicity as shown in previous studies in
neonates [25]. On the other hand, elevated FiO2 could also
indicate a greater need for oxygen, as worse tissue oxygen-
ation may exist. Nevertheless, no relationship was found
between PaO2 or PaO2/FiO2 and mortality in the patients
in our study, and it may be that these patients did not
require such a high FiO2. On the other hand we did not
find association between ventilation and oxygenation pa-
rameters and neurologic outcome. This may be because
the number of patients with hypoxia and hyperoxia wasrrest, resuscitation and post-return of spontaneous
dds ratio 95% CI P-value
2.633 1.072 to 6.469 0.035
5.528 1.726 to 17.701 0.004
3.170 1.707 to 5.887 <0.001
2.191 1.194 to 4.020 0.011
3.241 1.850 to 5.677 <0.001
2.623 1.076 to 6.397 0.034
2.004 1.011 to 3.970 0.046
4.611 1.934 to 10.993 <0.001
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important alterations in oxygenation could influence
neurologic outcome.
We think that it is possible that ventilation and oxygen-
ation could influence the prognosis of children who suffer
CA. However, multicenter controlled studies with a suffi-
cient number of patients are needed because many other
factors besides ventilation and oxygenation may influence
outcome in CA patients.
Lactid acid
Lactic acid is one of the most commonly used parame-
ters to assess and monitor hypoperfusion or tissue hyp-
oxia in critically ill patients, as it has been demonstrated
to have good prognostic capacity and it is easy and fast
to measure [26]. Lactate levels in patients who have re-
covered from CA probably reflect the severity of the
ischemia-reperfusion syndrome. Nevertheless, high lactic
acid levels may exist without the presence of tissue hy-
poperfusion due to the administration of adrenaline or
to the presence of hyperglycemia, which are very com-
mon after CA [26].
Several studies have found that lactate levels in the
first 48 hours after CA is lower in survivors and in pa-
tients without neurological damage [27-29]. The levels
of lactate after ROSC and 12 or 24 h later were signifi-
cantly higher in non survivors adults and children after
out-of-hospital and in-hospital CA [9,30-33]. Lactate
clearance within the first 24 hours (lactate after ROSC
minus lactate 24 hours after ROSC) × 100/lactate after
ROSC) is significantly higher in survivors than in non-
survivors [30-32].
In our study, non-survivors had more acidosis both at
1 hour and at 24 hours after ROSC. Acidosis was mainly
due to metabolic acidosis, with lower bicarbonate levels
and higher base deficit in non-survivors than in survi-
vors. Nevertheless, the only factor associated with mor-
tality in the logistic regression analysis was lactic acid at
1 hour and at 24 hours after ROSC. Non-survivors pre-
sented significantly higher levels of lactic acid at 1 and
24 hours after ROSC, and lactic acid levels >5 mmol/L
were associated with higher mortality in the univariate
and multivariate analysis.
Although lactate at 1 and at 24 hours after ROSC was
higher in non-survivors, no significant differences were
found in lactate clearance, because lactate acid levels sig-
nificantly decreased in the first 24 hours in both groups
(from 16.9 to 5.8 mmol/L in non-survivors and from 6.7
to 3.7 mmol/L in survivors).
Vasoactive treatment
Hemodynamic alterations after ROSC are also late
mortality risk factors. Cardiac rhythm after ROSC and
need for vasoactive drugs in the first 24 hours wereanalyzed in order to assess hemodynamic alterations.
Other hemodynamic parameters, such as heart rate, blood
pressure or central venous pressure were not registered.
The non-surviving group had a greater percentage of
patients requiring vasoactive support and at higher
doses (higher inotropic index) than the surviving group.
The univariate and multivariate studies showed that
vasoactive-inotropic score >14 was significantly associ-
ated with mortality.
Several studies have found that the need for pressors
previous to CA is a mortality risk factor, both in adults
[34-37] and in children [4,6,8,11]. Our study shows that
the need for pressors and at higher doses (vasoactive-
inotropic score) after CA is associated with higher risk
of mortality. This fact has also been found by Meert
et al. [9]. This highlights the influence of early
hemodynamic alterations on outcome in children after
CA, and the importance of treating these alterations
as they appear.
On the other hand, a large percentage of patients re-
ceived more than one vasoactive agent after ROSC. That
may be the cause for not finding a significant association
between mortality and the administration or dosage of
any specific vasoactive drug, but with the intensity of
vasoactive treatment in general. Inotropic score has
proved to be appropriate in assessing vasoactive support
and its relationship with mortality in several studies in
children in shock, after open heart surgery and after
heart transplantation [18,38,39]. Rhodes et al. found that
the inotropic score was higher in non-survivors than in
survivors with CA after congenital heart surgery [39].
Our study also suggests that the vasoactive-inotropic
score may be a useful prognostic indicator in children
after CA.
A recent retrospective study in adults showed that the
combination of elevated lactate levels and the need for
vasoactive support had a good mortality predictive cap-
acity in patients that recovered from CA [40]. Our
results agree with those from the mentioned study,
although in our study the dose of vasoactive support
also proved to have mortality predictive capacity. Fur-
thermore, PaCO2 levels, which were not registered in
the study in adults, also proved to have prognostic
capacity in our study. On the other hand, lactic acid
levels >5 mmol/L at 1 hour after ROSC was the only
factor that was associated with bad neurological out-
come in our study.
Pre-arrest, resuscitation and post-ROSC multivariate
analysis
Meert et al. [9] performed a multivariate analysis including
pre-arrest, resuscitation and 12 h post-ROSC factors. In this
study the only post-ROSC factor associated with survival al
hospital discharge was the responsive pupils after ROSC.
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arrest, resuscitation and post-ROSC factors, showed
that the post-ROSC factors associated with mortality
were hypoventilation and hyperventilation 1 hour after
ROSC and high FiO2 24 hours after ROSC, highlighting
the importance of the control of ventilation and oxygen-
ation after ROSC.
Limitations
Our study has several limitations. One of them is that
hemodynamic variables such as heart rate, blood pressure
and central venous pressure in the first 24 hours after ROSC
were not registered, making it impossible to accurately as-
sess the presence of shock in these patients. In a recent
study hypotension after ROSC was related to bad prognosis
[41]. Hypothermia or hyperthermia and the parameters of
mechanical ventilation were not registered neither.
Pre-arrest values of lactate or vasoactive-inotropic score
could influence post-ROSC values but we did not register
pre-arrest lactate and VIS data in our patients. On the
other hand, our study has only analyzed prognostic factors
in the first 24 hours after ROSC, which may be the most
important but not the only ones. Other factors that affect
prognosis but may appear in the following days, such as
nosocomial infections or multiple organ failure, were not
analyzed. Actually, the median PICU stay for non-
survivors was 8 days, and many of these patients died be-
cause of complications due to multi-organ failure.
Finally, only 61% of patients have neurologic outcome
evaluation, although there were no differences in base-
line characteristics between patients with and without a
neurologic outcome measure. On the other hand, only a
small number of patients had bad neurological out-
comes. This is why the power of the statistical analysis
in relationship with neurological outcome is poor, so re-
sults must be interpreted with caution. Therefore, more
studies are needed to prospectively assess both early and
late post-ROSC mortality and neurologic outcome risk
factors in children after CA.
Conclusions
We conclude that secondary in-hospital mortality among
the initial survivors of CA is high (43.5% in our study).
The most important early mortality risk factors after
ROSC in in-hospital CA in children are hyperventilation,
hypoventilation, high FiO2 requirements need for high
doses of inotropic drugs and high lactic acid levels. High
lactic acid levels at 1 hour after ROSC were associated
with bad neurological outcome.
Key messages
 Secondary in-hospital mortality among the initial
survivors of CA is high (43.5% in our study) The most important early mortality risk factors after
ROSC in-hospital CA in children were hyperventila-
tion, hypoventilation, need for high doses of ino-
tropic drugs, high lactic acid levels and high FiO2
requirements
 High lactic acid levels at 1 hour after ROSC were
associated with bad neurological outcome
 Early treatment of hemodynamic and respiratory
disturbances after ROSC could improve mortality in
initial survivors of CA
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